Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ann Vasc Surg ; 25(3): 413-22, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21396568

RESUMO

In 1990, Dalman and Taylor published a compilation of reported data that were identified by them as related to infrainguinal revascularization procedures in peripheral vascular surgery during the decade of the 1980s. The intervening 20 years has seen revolutionary advances in the field of peripheral vascular surgery, especially in the adoption of endovascular techniques, and an explosion of data related to emerging technologies in the field of infrainguinal revascularization. The tables in this manuscript reflect the evolution of our surgical knowledge during the turn of the 21st century. The superior patency of autologous saphenous vein in all positions is reaffirmed.


Assuntos
Procedimentos Endovasculares , Doenças Vasculares Periféricas/cirurgia , Procedimentos Cirúrgicos Vasculares , Procedimentos Endovasculares/efeitos adversos , Oclusão de Enxerto Vascular/etiologia , Oclusão de Enxerto Vascular/terapia , Humanos , Doenças Vasculares Periféricas/fisiopatologia , Reoperação , Veia Safena/transplante , Fatores de Tempo , Resultado do Tratamento , Grau de Desobstrução Vascular , Procedimentos Cirúrgicos Vasculares/efeitos adversos
2.
Ann Vasc Surg ; 25(4): 561-8, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21276709

RESUMO

Bovine pericardium (BP) is widely used in surgery and is commonly used as a patch after arteriotomy in cardiovascular surgery. BP patches have several advantages compared with prosthetic patches, including superior biocompatability, easy handling, less suture line bleeding, and possibly reduced rates of infection. These advantages of BP have led to its common use during carotid endarterectomy (CEA). However, long-term clinical results reported after CEA have suggested several issues that may be related to the patch, including restenosis, pseudoaneurysm formation, infection, fibrosis, calcification, and thrombosis. These complications may diminish the long-term efficacy of CEA and suggest potential areas for improvement of surgical patches. Understanding the mechanisms by which BP heals after patch angioplasty may lead to next generation tissue-engineered patches.


Assuntos
Materiais Biocompatíveis , Procedimentos Cirúrgicos Cardíacos/instrumentação , Doenças Cardiovasculares/cirurgia , Pericárdio/transplante , Procedimentos Cirúrgicos Vasculares/instrumentação , Animais , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Bovinos , Endarterectomia das Carótidas/instrumentação , Humanos , Resultado do Tratamento , Procedimentos Cirúrgicos Vasculares/efeitos adversos , Cicatrização
3.
Circ J ; 74(8): 1501-12, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20606326

RESUMO

For patients with coronary artery disease or limb ischemia, placement of a vein graft as a conduit for a bypass is an important and generally durable strategy among the options for arterial reconstructive surgery. Vein grafts adapt to the arterial environment, and the limited formation of intimal hyperplasia in the vein graft wall is thought to be an important component of successful vein graft adaptation. However, it is also known that abnormal, or uncontrolled, adaptation may lead to abnormal vessel wall remodeling with excessive neointimal hyperplasia, and ultimately vein graft failure and clinical complications. Therefore, understanding the venous-specific pathophysiological and molecular mechanisms of vein graft adaptation are important for clinical vein graft management. Of particular importance, it is currently unknown whether there exist several specific distinct molecular differences in the venous mechanisms of adaptation that are distinct from arterial post-injury responses; in particular, the participation of the venous determinant Eph-B4 and the vascular protective molecule Nogo-B may be involved in mechanisms of vessel remodeling specific to the vein. This review describes (1) venous biology from embryonic development to the mature quiescent state, (2) sequential pathologies of vein graft neointima formation, and (3) novel candidates for strategies of vein graft management. Scientific inquiry into venous-specific adaptation mechanisms will ultimately provide improvements in vein graft clinical outcomes.


Assuntos
Artérias/fisiologia , Circulação Sanguínea/fisiologia , Veias/transplante , Adaptação Fisiológica , Artérias/cirurgia , Humanos , Neointima , Enxerto Vascular/métodos
4.
J Gerontol A Biol Sci Med Sci ; 67(2): 109-17, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22016364

RESUMO

Carotid angioplasty is associated with adverse events in elderly patients; it is unclear whether this is related to an altered inflammatory axis. The carotid arteries of young (6 months) or aged (22-24 months) Fischer 344 rats were balloon injured. Aged rats had reduced lumen area (0.18 ± 0.03 vs 0.24 ± 0.01 mm(2), p = .02) and increased neointimal thickening (0.15 ± 0.04 vs 0.08 ± 0.03 mm(2), p = .006). Aged rats had increased circulating monocytes (96 ± 21 vs. 54 ± 7; p = .002) as well as increased numbers of monocytes at the post-angioplasty site. Aged rats had sustained monocyte chemotactic protein-1 expression after angioplasty but young rats did not. Aged arteries also exhibited defective vasorelaxation and abnormal eNOS localization. Aged (≥80 years) human patients with high-grade carotid stenosis had increased number of monocytes (9.1% ± 0.4%) compared with younger (65-80 years) patients (8.1% ± 0.3%, p = .013). Aged rats develop neointimal hyperplasia after carotid angioplasty with increased numbers of monocytes, and elderly humans with carotid stenosis have increased numbers of circulating monocytes. These preliminary results may suggest a role for monocytes in the response to carotid angioplasty.


Assuntos
Envelhecimento/patologia , Angioplastia com Balão/efeitos adversos , Artérias Carótidas/patologia , Lesões das Artérias Carótidas/patologia , Quimiocina CCL2/biossíntese , Monócitos/patologia , Neointima/patologia , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/metabolismo , Animais , Lesões das Artérias Carótidas/etiologia , Lesões das Artérias Carótidas/metabolismo , Quimiocina CCL2/genética , Modelos Animais de Doenças , Eletroforese em Gel de Ágar , Regulação da Expressão Gênica , Humanos , Hiperplasia , Monócitos/metabolismo , Neointima/metabolismo , RNA/genética , Ratos , Ratos Endogâmicos F344 , Reação em Cadeia da Polimerase Via Transcriptase Reversa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA